These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16837083)

  • 1. Cyclooxygenase-2 inhibitors dilemma in cardiovascular medicine: are all family members bad players?
    Celik T; Iyisoy A; Kursaklioglu H; Yuksel UC
    Int J Cardiol; 2007 Mar; 116(2):259-60. PubMed ID: 16837083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 controversy: where are we and where do we go from here?
    Khanna D; Khanna PP; Furst DE
    Inflammopharmacology; 2005; 13(4):395-402. PubMed ID: 16354392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ; Islam K
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors and heart.
    Manoria P; Manoria PC
    Indian Heart J; 2005; 57(6):772-7. PubMed ID: 16521658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Selective cyclooxygenase-2 inhibitors for the prevention of colorectal adenomas: a meta-analysis].
    Jin XF; Tong JL; Ran ZH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1958-61. PubMed ID: 17923032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 inhibitors and cardiovascular risk.
    Funk CD; FitzGerald GA
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):470-9. PubMed ID: 18030055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
    Joshi GP; Gertler R; Fricker R
    Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ; Benraad HB; Rasker JJ
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing of COX-2 inhibitors in Germany after safety warnings and market withdrawals.
    Schüssel K; Schulz M
    Pharmazie; 2006 Oct; 61(10):878-86. PubMed ID: 17069430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What happened to the prescribing of other COX-2 inhibitors, paracetamol and non-steroidal anti-inflammatory drugs when rofecoxib was withdrawn in Australia?
    Barozzi N; Tett SE
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1184-91. PubMed ID: 17636557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M; Ruschitzka F
    Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.
    Salinas G; Rangasetty UC; Uretsky BF; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):98-111. PubMed ID: 17562780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B; Renner B; Brune K
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is new about nonsteroidal antiinflamatory drugs?].
    Dzielska-Olczak M
    Pol Merkur Lekarski; 2007 Dec; 23(138):454-8. PubMed ID: 18432131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2 selective inhibitors and heart health.
    Simon LS; White WB
    Postgrad Med; 2005 Jan; 117(1 Suppl):7-20. PubMed ID: 19667717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
    Lange H; Eberhart L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.